Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

49 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Visit 1 Run-In Demographics NCT01117584

- 28/1/17 - 1 formulario, 1 itemgroup, 6 items, 1 idioma
Itemgroup: General Information
NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.

Diabetes (clinical) DSS Metadata Online Registry (METeOR)

- 2/9/16 - 1 formulario, 7 itemgroups, 52 items, 1 idioma
Itemgroups: Female, Health service event, Laboratory standard, Patient, Person (male), Person, Service contact
Health sector data set specifications from METeOR, Australia's repository for national metadata standards, developed by the Australian Institute of Health and Welfare (http://meteor.aihw.gov.au/content/index.phtml/itemId/345165) Diabetes (clinical) DSS The use of this standard is voluntary. However, if data is to be collected the Diabetes (clinical) Data Set Specification (DSS) aims to ensure national consistency in relation to defining, monitoring and recording information on patients diagnosed with diabetes. The Diabetes (clinical) DSS relates to the clinical status of, the provision of services for, and the quality of care delivered to individuals with diabetes, across all health care settings including: · General Practitioners; · Divisions of General Practice; · Diabetes Centres · Specialists in private practice; and · Community Health Nurses and Diabetes Educators. The Diabetes (clinical) DSS: · provides concise, unambiguous definitions for items/conditions related to diabetes quality care, and · aims to ensure standardised methodology of data collection in Australia. The expectation is that collection of this data set facilitates good quality of care, contributes to preventive care and has the potential to enhance self-management by patients with diabetes. The underlying goal is improvement of the length and quality of life of patients with diabetes, and prevention or delay in the development of diabetes related complications. © Australian Institute of Health and Welfare 2015 Metadata and Classifications Unit Australian Institute of Health and Welfare GPO Box 570 Canberra ACT 2601

Eligibility Diabetes NCT01620463

- 10/6/16 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT01620463

Eligibility Diabetes NCT01511198

- 25/5/16 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent; ODM derived from: https://clinicaltrials.gov/show/NCT01511198

Eligibility Diabetes NCT01697657

- 24/5/16 - 1 formulario, 2 itemgroups, 16 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01697657

Eligibility Diabetes NCT01620424

- 24/5/16 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01620424

Eligibility Diabetes NCT02246959

- 17/5/16 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Process Versus Outcomes Incentives for Lipid Management; ODM derived from: https://clinicaltrials.gov/show/NCT02246959

Eligibility Diabetes NCT02215408

- 17/5/16 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention; ODM derived from: https://clinicaltrials.gov/show/NCT02215408

Eligibility Diabetes NCT00789711

- 21/12/15 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00789711

Eligibility Acute Heart Failure NCT00922402

- 3/12/15 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion criteria, Exclusion criteria
Heart & Diabetes - Feasibility Study; ODM derived from: https://clinicaltrials.gov/show/NCT00922402

Eligibility Diabetes NCT02117622

- 17/11/15 - 1 formulario, 2 itemgroups, 8 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India; ODM derived from: https://clinicaltrials.gov/show/NCT02117622

Eligibility Diabetes Mellitus Type 2 NCT02160639

- 17/11/15 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support; ODM derived from: https://clinicaltrials.gov/show/NCT02160639

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial